Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses rich behavioral details beyond the read-only/idempotent annotations: it cascades across multiple lookup endpoints, degrades gracefully when GLEIF/OpenFIGI are unavailable, marks unresolved identifiers explicitly, and returns figi_candidates in ambiguous name matches. These details give the agent a clear picture of expected behavior and failure modes.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with examples and the 'use first' rule, and the detailed caveats are all relevant for correct invocation. It could be tightened slightly, but the structure helps navigate the complexity of multiple identifiers and edge cases.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description is remarkably complete: it explains accepted inputs, what identifiers are returned for each type, how ambiguity and unresolved identifiers are handled, and how to phrase input values correctly. The enrichment-failure behavior and ISIN-to-LEI mapping also cover important edge cases an agent would otherwise not anticipate.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema describes both parameters at 100% coverage, the description adds essential semantic nuance, especially for `value`: 'Pass the ENTITY NAME ONLY', avoid trailing security-class words, and accept ticker, CIK, ISIN, or name for companies. It also clarifies the `type` enum by explaining what resolution means for 'company' versus 'drug'. This goes well beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's core function: resolving user-spoken names to canonical/official identifiers like CIK, LEI, FIGI, and RxCUI. It uses concrete examples ('What's the ticker for…', 'find the CIK for…') and distinguishes supported entity types, making its purpose immediately understandable and distinct from sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit guidance: 'Use FIRST whenever you have a name but need an ID.' It also clarifies when each supported type applies and notes that the tool replaces 2-3 manual lookups. It does not explicitly name sibling alternatives or state when not to use it, but the 'use first' directive and detailed type guidance provide strong usage context.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-duplicates (beta is currently identical), and the five Polymarket tools (arbitrage, edges, edge_tracker, fill_risk, kalshi_spread) require careful reading to distinguish. Additionally, entity_profile, compare_entities, and recent_changes all handle company data, and ai_visibility_check vs scan_competitor_ai_presence are clearly paired. The detailed descriptions help, but an agent will frequently misselect among these clusters.

Naming Consistency3/5

All names are lowercase with underscores, so the style is internally consistent. However, the pattern is mixed: many use verb_noun (get_positions, list_subscriptions, resolve_entity) but several are noun-first or noun-only (entity_profile, polymarket_edges, pipeworx_trending, bet_research). There's no strong verb/noun convention across the set, making the naming pattern less predictable than it could be.

Tool Count2/5

With 34 tools, the set exceeds the 16–25 'heavy' range and sits in the 'too many' band. The server name suggests a focused satellite-tracking service, yet only 3 tools (get_positions, get_visual_passes, whats_above) serve that purpose; the other 31 cover unrelated domains like data research, prediction markets, memory, and subscriptions. Even as a general-purpose research platform, the count feels bloated and unfocused.

Completeness3/5

The tool surface is broad, covering satellite tracking, data research, prediction markets, subscriptions, and memory, and within each cluster the main operations exist (e.g., subscription lifecycle, edge analysis + fill risk). However, the scattered scope creates gaps: there's no direct raw-data fetch tool (everything goes through ask_pipeworx), no general web search, and the presence of unrelated utilities (generate_llms_txt, scan_dependency) suggests the domain boundaries are unclear. For its stated satellite purpose, the satellite tools are thin (no TLE, no catalog, no detailed orbit info).